Chandra Bhagat Pharma Ltd.

View in App
110.00 ▼0%

28 September 2023, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cbcpharma.com
Market Cap 83.00 Cr.
Enterprise Value(EV) 101.94 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.20 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 91.81 Trailing Twelve Months Ending 2023-03
Industry PE 37.76 Trailing Twelve Months Ending 2023-03
Book Value / Share 36.42 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.02 Calculated using Price: 110.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.75 Cr. 7,545,056 Shares
FaceValue 10
About Chandra Bhagat Pharma Ltd.
The company is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. It provides pharmaceuticals and special chemical products in the Indian and international market. It has wide range of products portfolio of pharmaceutical formulation including IV & IM range Injections, few tablets to cater the Domestic & Export Market.

Chandra Bhagat Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Chandra Bhagat Pharma Ltd. Performance

View details >>
1 Day
1 Week
-7.49%
1 Month
-16.67%
3 Month
-15.38%
6 Month
+13.40%
1 Year
+3.53%
2 Year
-21.43%
5 Year
10 Year

Chandra Bhagat Pharma Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 7.53 6.89 5.38 9.33 13.44 6.46 1.67 0.78 3.19
Return on Capital Employed (%) 11.66 10.40 12.62 14.34 17.58 13.40 7.16 7.63 8.83
Return on Assets (%) 1.27 1.16 0.82 1.32 1.82 0.98 0.40 0.26 1.10

Chandra Bhagat Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 6 6 7 7 8 14 26 26 27 27
Non Curr. Liab. 0 0 0 11 21 16 15 13 8 6
Curr. Liab. 26 36 38 37 29 53 34 33 38 27
Minority Int.
Equity & Liab. 32 42 44 56 58 83 75 72 72 61
Non Curr. Assets 1 1 1 1 1 0 0 0 0 2
Curr. Assets 31 41 44 55 57 81 73 70 71 59
Misc. Exp. not W/O 0 1 1 1 1
Total Assets 32 42 44 56 58 83 75 72 72 61

Chandra Bhagat Pharma Ltd. Profit and Loss

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 35 48 61 80 90 97 106 94 71 94
Other Income 1 0 0 0 1 0 0 0 2
Total Income 35 49 61 80 90 98 107 94 71 96
Total Expenditure -35 -46 -58 -76 -85 -92 -102 -91 -67 -91
PBIDT 0 2 3 5 5 5 5 4 4 4
Interest -2 -2 -4 -4 -4 -4 -3 -4 -3
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 -1 0 0 0 0
Exceptional Items
PAT 0 0 0 0 1 1 1 0 0 1
Adjusted EPS 9 8 10 8 2 3 1 0 0 1

Chandra Bhagat Pharma Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -9 -6 4 -7 8 12
Cash Fr. Inv. 0 0 0 0 0 0
Cash Fr. Finan. 8 7 -4 7 -6 -10
Net Change -1 0 0 0 2 3
Cash & Cash Eqvt 1 1 0 0 3 6

Chandra Bhagat Pharma Ltd. Shareholding Pattern

View details >>
7 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%) 2023-03 (%)
Promoter 70.42 70.42 71.80 71.80 70.11 69.09 68.24
Public 29.58 29.58 28.20 28.20 29.89 30.91 31.76
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Chandra Bhagat Pharma Ltd. Announcements

View details >>
Sun, 01 Oct 2023
Closure of Trading Window
Disclosure for Closure of Trading Window.
Sat, 30 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizers Report on the Annual General Meeting of the Company.
Sat, 30 Sep 2023
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceeding of Annual General Meeting held on 30th September 2023.

Chandra Bhagat Pharma Ltd. Technical Scans

View details >>
Thu, 28 Sep 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Chandra Bhagat Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,145.40 1,121.75 -1.8%
Divi's Laboratories Ltd. 98,393.27 3,702.05 -0.5%
Cipla Ltd. 94,222.95 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. 90,284.76 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. 72,588.97 5,048.70 -1.4%
Mankind Pharma Ltd. 72,396.35 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. 63,113.31 1,865.70 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.91 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 66.52 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 30.29 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.12 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.58 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.53 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.11 1,865.70 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.64 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-06 7.49 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-06 3.87 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.68 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.57 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.92 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.60 1,865.70 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,865.70 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,865.70 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,121.75 -1.8%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,702.05 -0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.10 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,413.25 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,048.70 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.95 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,865.70 -0.8%

Chandra Bhagat Pharma Ltd. FAQ's

What is Chandra Bhagat Pharm share price?
Can I buy Chandra Bhagat Pharm shares now?
What is the Market Cap of Chandra Bhagat Pharm?
What are the key metrics to analyse Chandra Bhagat Pharm?
What is the 52 Week High and Low of Chandra Bhagat Pharm?